MYRIAD GENETICS, INC. (MYGN) Operating margin 2016–2025
MYRIAD GENETICS, INC. (MYGN) operating margin by fiscal year — reported operating income divided by reported revenue.
-47.0%FY2025 · since FY2016: 20.7% → -47.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -47.0% | -32.2 pp |
| FY2024 | -14.7% | +19.4 pp |
| FY2023 | -34.2% | -13.4 pp |
| FY2022 | -20.7% | +6.9 pp |
| FY2021 | -27.6% | +24.4 pp |
| FY2020 | -52.0% | -52.9 pp |
| FY2019 | 0.9% | -15.5 pp |
| FY2018 | 16.4% | +10.4 pp |
| FY2017 | 6.0% | -14.7 pp |
| FY2016 | 20.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice